1
IN HOUSE DISCOVERY
Targeting difficult to treat cancer
2
LICENSE OUT
Extra programs on pipeline
3
CO-DEVELOPMENT
Targeting CNS diseases
4
PARTNERSHIP AND SERVICE
Three patented novel technology platforms: Partnership
CAAD for regular therapeutic antibody design: Service
COMPANY
Ab Studio Inc. is a start-up Biotech founded in Feb., 2017 in San Francisco bay area, USA. Founder and leading scientist have extensive expertise in the field of therapeutic antibody discovery, lead selection, engineering, humanization and optimization.
We look forward to developing novel therapeutic antibodies to target difficult to treat diseases via computer aided design.